152 related articles for article (PubMed ID: 8496932)
1. Inhibitors of acyl-CoA:cholesterol acyltransferase (ACAT). 2. Modification of fatty acid anilide ACAT inhibitors: bioisosteric replacement of the amide bond.
Roark WH; Roth BD; Holmes A; Trivedi BK; Kieft KA; Essenburg AD; Krause BR; Stanfield RL
J Med Chem; 1993 May; 36(11):1662-8. PubMed ID: 8496932
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of acyl-CoA:cholesterol acyltransferase (ACAT). 7. Development of a series of substituted N-phenyl-N'-[(1-phenylcyclopentyl)methyl]ureas with enhanced hypocholesterolemic activity.
Trivedi BK; Purchase TS; Holmes A; Augelli-Szafran CE; Essenburg AD; Hamelehle KL; Stanfield RL; Bousley RF; Krause BR
J Med Chem; 1994 May; 37(11):1652-9. PubMed ID: 8201599
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship of a series of phenylureas linked to 4-phenylimidazole. Novel potent inhibitors of acyl-CoA:cholesterol O-acyltransferase with antiatherosclerotic activity. 2.
Kimura T; Watanabe N; Matsui M; Hayashi K; Tanaka H; Ohtsuka I; Saeki T; Kogushi M; Kabayashi H; Akasaka K
J Med Chem; 1993 May; 36(11):1641-53. PubMed ID: 8496931
[TBL] [Abstract][Full Text] [Related]
4. Bioisosterism in drug design: identification of and structure-activity relationships in a series of glycine anilide ACAT inhibitors.
Roark WH; Padia J; Bolton GL; Blankley CJ; Essenburg AD; Stanfield RL; Bousley RF; Krause BR; Roth BD
Bioorg Med Chem; 1995 Jan; 3(1):29-39. PubMed ID: 8612044
[TBL] [Abstract][Full Text] [Related]
5. Inhibitors of acyl-Coa:cholesterol acyltransferase. 4. A novel series of urea ACAT inhibitors as potential hypocholesterolemic agents.
Trivedi BK; Holmes A; Stoeber TL; Blankley CJ; Roark WH; Picard JA; Shaw MK; Essenburg AD; Stanfield RL; Krause BR
J Med Chem; 1993 Oct; 36(22):3300-7. PubMed ID: 8230120
[TBL] [Abstract][Full Text] [Related]
6. Novel acyl-CoA:cholesterol acyltransferase inhibitors. Synthesis and biological activity of 3-quinolylurea derivatives.
Tawada H; Harcourt M; Kawamura N; Kajino M; Ishikawa E; Sugiyama Y; Ikeda H; Meguro K
J Med Chem; 1994 Jun; 37(13):2079-84. PubMed ID: 8027989
[TBL] [Abstract][Full Text] [Related]
7. Inhibitors of acyl-CoA:cholesterol O-acyltransferase. synthesis and pharmacological activity of (+/-)-2-dodecyl-alpha-phenyl-N-(2,4,6-trimethoxyphenyl)-2H-tetrazole-5- acetamide and structurally related tetrazole amide derivatives.
O'Brien PM; Sliskovic DR; Picard JA; Lee HT; Purchase CF; Roth BD; White AD; Anderson M; Mueller SB; Bocan T; Bousley R; Hamelehle KL; Homan R; Lee P; Krause BR; Reindel JF; Stanfield RL; Turluck D
J Med Chem; 1996 Jun; 39(12):2354-66. PubMed ID: 8691430
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship of N-[2-(dimethylamino)-6-[3-(5-methyl-4-phenyl-1H-imidazol-1-yl)propoxy] phenyl]-N'-pentylurea and analogues. Novel potent inhibitors of acyl-CoA:cholesterol O-acyltransferase with antiatherosclerotic activity.
Kimura T; Takase Y; Hayashi K; Tanaka H; Ohtsuka I; Saeki T; Kogushi M; Yamada T; Fujimori T; Saitou I
J Med Chem; 1993 May; 36(11):1630-40. PubMed ID: 8496930
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of acyl-CoA:cholesterol O-acyl transferase (ACAT) as hypocholesterolemic agents. 8. Incorporation of amide or amine functionalities into a series of disubstituted ureas and carbamates. Effects on ACAT inhibition in vitro and efficacy in vivo.
O'Brien PM; Sliskovic DR; Blankley CJ; Roth BD; Wilson MW; Hamelehle KL; Krause BR; Stanfield RL
J Med Chem; 1994 Jun; 37(12):1810-22. PubMed ID: 8021920
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of acyl-CoA:cholesterol acyltransferase. 5. Identification and structure-activity relationships of novel beta-ketoamides as hypocholesterolemic agents.
Augelli-Szafran CE; Blankley CJ; Roth BD; Trivedi BK; Bousley RF; Essenburg AD; Hamelehle KL; Krause BR; Stanfield RL
J Med Chem; 1993 Oct; 36(20):2943-9. PubMed ID: 8411011
[TBL] [Abstract][Full Text] [Related]
11. Inhibitors of acyl-CoA:cholesterol acyltransferase. 1. Synthesis and hypocholesterolemic activity of dibenz[b,e]oxepin-11-carboxanilides.
Kumazawa T; Yanase M; Harakawa H; Obase H; Shirakura S; Ohishi E; Oda S; Kubo K; Yamada K
J Med Chem; 1994 Mar; 37(6):804-10. PubMed ID: 8145231
[TBL] [Abstract][Full Text] [Related]
12. Inhibitors of acyl-CoA:cholesterol O-acyltransferase (ACAT). Part 1: identification and structure-activity relationships of a novel series of substituted N-alkyl-N-biphenylylmethyl-N'-arylureas.
Tanaka A; Terasawa T; Hagihara H; Sakuma Y; Ishibe N; Sawada M; Takasugi H; Tanaka H
Bioorg Med Chem; 1998 Jan; 6(1):15-30. PubMed ID: 9502102
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of acyl-CoA:cholesterol O-acyltransferase. 3. Discovery of a novel series of N-alkyl-N-[(fluorophenoxy)benzyl]-N'-arylureas with weak toxicological effects on adrenal glands.
Tanaka A; Terasawa T; Hagihara H; Ishibe N; Sawada M; Sakuma Y; Hashimoto M; Takasugi H; Tanaka H
J Med Chem; 1998 Oct; 41(22):4408-20. PubMed ID: 9784116
[TBL] [Abstract][Full Text] [Related]
14. Structure-activity relationships of N-(3,5-dimethoxy-4-n-octyloxycinnamoyl)-N'-(3,4-dimethylphenyl)piperazine and analogues as inhibitors of acyl-CoA: cholesterol O-acyltransferase.
Ohishi K; Aiyama R; Hatano H; Yoshida Y; Wada Y; Yokoi W; Sawada H; Watanabe T; Yokokura T
Chem Pharm Bull (Tokyo); 2001 Jul; 49(7):830-9. PubMed ID: 11456087
[TBL] [Abstract][Full Text] [Related]
15. Relationships between lipophilicity and biological activities in a series of indoline-based anti-oxidative acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors.
Takahashi K; Kunishiro K; Kasai M; Miike T; Kurahashi K; Shirahase H
Arzneimittelforschung; 2008; 58(12):666-72. PubMed ID: 19202739
[TBL] [Abstract][Full Text] [Related]
16. Potent inhibitors of acyl-CoA:cholesterol acyltransferase. 2. Structure-activity relationships of novel N-(2,2-dimethyl-2,3-dihydrobenzofuran-7-yl)amides.
Kataoka K; Shiota T; Takeyasu T; Minoshima T; Watanabe K; Tanaka H; Mochizuki T; Taneda K; Ota M; Tanabe H; Yamaguchi H
J Med Chem; 1996 Mar; 39(6):1262-70. PubMed ID: 8632433
[TBL] [Abstract][Full Text] [Related]
17. Inhibitors of acyl-CoA:cholesterol O-acyltransferase. 2. Identification and structure-activity relationships of a novel series of N-alkyl-N-(heteroaryl-substituted benzyl)-N'-arylureas.
Tanaka A; Terasawa T; Hagihara H; Sakuma Y; Ishibe N; Sawada M; Takasugi H; Tanaka H
J Med Chem; 1998 Jun; 41(13):2390-410. PubMed ID: 9632372
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of acyl-CoA:cholesterol acyltransferase: novel trisubstituted ureas as hypocholesterolemic agents.
Purchase TS; Essenburg AD; Hamelehle KL; Hes MS; Holmes A; Krause BR; Stanfield RL; Trivedi BK
Bioorg Med Chem; 1997 Apr; 5(4):739-47. PubMed ID: 9158873
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and structure-activity relationship studies of novel 4,4-bis(trifluoromethyl)imidazolines as acyl-CoA: cholesterol acyltransferase (ACAT) inhibitors and antihypercholesterolemic agents.
Li HY; DeLucca I; Boswell GA; Billheimer JT; Drummond S; Gillies PJ; Robinson C
Bioorg Med Chem; 1997 Jul; 5(7):1345-61. PubMed ID: 9377095
[TBL] [Abstract][Full Text] [Related]
20. Acyl CoA:cholesterol acyltransferase (ACAT) inhibitors: synthesis and structure-activity relationship studies of a new series of trisubstituted imidazoles.
Higley CA; Wilde RG; Maduskuie TP; Johnson AL; Pennev P; Billheimer JT; Robinson CS; Gillies PJ; Wexler RR
J Med Chem; 1994 Oct; 37(21):3511-22. PubMed ID: 7932580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
